ALPS ADVISORS INC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$920,120
-31.3%
78,710
-21.0%
0.01%
-33.3%
Q2 2023$1,338,543
-10.4%
99,594
+10.5%
0.01%
-7.7%
Q1 2023$1,493,742
-11.9%
90,093
-1.1%
0.01%
-13.3%
Q4 2022$1,694,572
+71.9%
91,106
+18.6%
0.02%
+66.7%
Q3 2022$986,000
+31.8%
76,815
-28.0%
0.01%
+28.6%
Q2 2022$748,000
-40.7%
106,758
-29.9%
0.01%
-50.0%
Q1 2022$1,262,000
-4.2%
152,241
-21.7%
0.01%
-6.7%
Q4 2021$1,317,000
+24.0%
194,494
-2.9%
0.02%
+50.0%
Q3 2021$1,062,000
-15.2%
200,400
-8.0%
0.01%
-9.1%
Q2 2021$1,253,000
+1.0%
217,878
-19.1%
0.01%
-8.3%
Q1 2021$1,241,000
+40.2%
269,260
+1.6%
0.01%
+20.0%
Q4 2020$885,000
+40.3%
265,002
+24.8%
0.01%
+11.1%
Q3 2020$631,000
-3.2%
212,303
+50.5%
0.01%0.0%
Q2 2020$652,000
-9.6%
141,080
-24.7%
0.01%
-18.2%
Q1 2020$721,000
-8.0%
187,348
-10.4%
0.01%
+83.3%
Q4 2019$784,000
-38.1%
209,190
-15.7%
0.01%
-33.3%
Q1 2019$1,266,000
+177.6%
248,154
+4.5%
0.01%
+125.0%
Q4 2018$456,000
-33.5%
237,439
+30.8%
0.00%
-20.0%
Q3 2018$686,000
+47.5%
181,555
+21.9%
0.01%
+66.7%
Q2 2018$465,000
+41.8%
148,894
+8.3%
0.00%0.0%
Q1 2018$328,000
-24.6%
137,441
+23.6%
0.00%0.0%
Q4 2017$435,000111,1790.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders